Scientists of the State Research Center of Virology and Biotechnology (GNTSVB) "Vector" developed a DNA vaccine against smallpox, Crimean-Congo hemorrhagic fever and hemorrhagic fever with renal syndrome, told the CEO GNTSVB Alexander Sergeyev.
"On the" vector "works on pre-clinical studies of three vaccines based on DNA. That is, the DNA vaccine — Ultra-modern drugs against smallpox, Crimean-Congo hemorrhagic fever and hemorrhagic fever with renal syndrome. The results of these studies show promise in animal use and subsequent promotion to conduct clinical trials, "- he said.
Also in 2012, was developed inactivated vaccine against West Nile.
"Efficiency is also confirmed in its immunogenicity tests for animals. Expect to get permission for the next year or this year to conduct clinical trials of the drug, "- said Sergeyev.
According to him, completed medical tests multiplex test systems for tick-borne infections. Four of them — that's tick-borne encephalitis, Lyme disease, typhus, West Nile fever.
General Director of "Vector" reported that the test system is under registration in the Ministry of Health of the Russian Federation. In addition to her at this stage are a test system for the identification of particularly dangerous infections, such as Marburg, Ebola, Lassa, Junin, Machupo, dengue 2.
Total in 2012, according to Sergeeva, "Vector" has been working on 97 research topics.